Table S1.
Strains, number, and age of mice used in various analyses and assays in this study
| Assessment | n | Age, postnatal days |
| ERG analysis of retinal function | ||
| WT | 11 | 35 |
| Rd10-non | 6 | 35 |
| Rd10+PTZ | 9 | 35 |
| Rd10/Sig1R−/− | 5 | 35 |
| Rd10/Sig1R−/−+PTZ | 3 | 35 |
| OCT analysis of retinal structure (in vivo imaging) | ||
| WT | 5 | 21 |
| Rd10-non | 7 | 21 |
| Rd10+PTZ | 9 | 21 |
| Rd10/Sig1R−/− | 4 | 21 |
| Rd10/Sig1R−/−+PT | 4 | 21 |
| WT | 4 | 28 |
| Rd10-non | 4 | 28 |
| Rd10+PTZ | 9 | 28 |
| WT | 4 | 35 |
| Rd10-non | 5 | 35 |
| Rd10+PTZ | 7 | 35 |
| WT | 4 | 42 |
| Rd10-non | 10 | 42 |
| Rd10+PTZ | 9 | 42 |
| Rd10/Sig1R−/− | 5 | 42 |
| Rd10/Sig1R−/−+PTZ) | 3 | 42 |
| Morphometry, immunohistochemistry, TUNEL assay | ||
| WT | 15 | 42 |
| Rd10-non | 12 | 42 |
| Rd10+PTZ | 15 | 42 |
| Rd10/Sig1R−/− | 3 | 42 |
| Rd10/Sig1R−/−+PTZ) | 3 | 42 |
| Assessment of microglia activation and PNA-labeled cones in flatmount preparation | ||
| WT | 7 | 42 |
| Rd10-non | 8 | 42 |
| Rd10+PTZ | 10 | 42 |
| Rd10/Sig1R−/− | 6 | 42 |
| Rd10/Sig1R−/−+ | 6 | 42 |
| Detection of oxidative stress and Nrf2-induced antioxidant genes | ||
| WT | 8 | 42 |
| Rd10-non | 10 | 42 |
| Rd10+PTZ | 12 | 42 |